C. Köhler, H. Hall, O. Magnusson, T. Lewander i inni. Biochemical pharmacology of the atypical neuroleptic remoxipride. „Acta Psychiatr Scand Suppl”. 82 (S358), s. 27–36, 1990. DOI: 10.1111/j.1600-0447.1990.tb05282.x. PMID: 1978484.
R. Conley, C. Tamminga, J. An Nguyen, R. Hain. Remoxipride therapy in treatment resistant schizophrenia. „Schizophrenia Research”. 9 (2–3), s. 235–236, 1993. DOI: 10.1016/0920-9964(93)90521-J.
M.S. Alexander, S.K. Chakravarti, K. Sundararajan, J.M. Mullin i inni. Once-daily controlled release remoxipride is equieffective with twice-daily immediate release remoxipride in the treatment of schizophrenia. „J Psychopharmacol”. 7 (3), s. 276–282, 1993. DOI: 10.1177/026988119300700307. PMID: 22290842.
nih.gov
ncbi.nlm.nih.gov
C. Köhler, H. Hall, O. Magnusson, T. Lewander i inni. Biochemical pharmacology of the atypical neuroleptic remoxipride. „Acta Psychiatr Scand Suppl”. 82 (S358), s. 27–36, 1990. DOI: 10.1111/j.1600-0447.1990.tb05282.x. PMID: 1978484.
M.S. Alexander, S.K. Chakravarti, K. Sundararajan, J.M. Mullin i inni. Once-daily controlled release remoxipride is equieffective with twice-daily immediate release remoxipride in the treatment of schizophrenia. „J Psychopharmacol”. 7 (3), s. 276–282, 1993. DOI: 10.1177/026988119300700307. PMID: 22290842.
